1Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma [J]. Angiogenesis, 2009, 12 (2) : 197-207.
2Kuhnert F, am BY,Sennino B,et al. Soluble receptor-mediated selective inhibition of VEGFR and PDGFR beta signaling during phys, iologic and tumor angiogenesis [J]. Proc Natl Acad Sci U S A, 2008, 105 (29) : 10185-10190.
4Doherty M J, Ashton BA, Walsh S, et al. Vascular pericytes express osteogenic potential in vitro and in vivo [J]. J Bone Miner Res, 1998, 13 (5) : 828-838.
5Collett GD, Canfield AE. Angiogenesis and pericytes in the initiation of ectopic calcification [J]. Circ Res, 2005,96 (9) : 930-938,.
6Corselli M, Chen CW, Crisan M, et al. Perivascular ancestors of adult muhipotent stem cells [J]. Arterioscler Thromb Vasc Biol, 2010, 30 (6) : 1104-1109.
7Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem ceils in human bone marrow and dental pulp [J]. J Bone Miner Res, 2003, 18 (4) : 696-704.
8Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenehymal stem-like cells from human endometrium[J]. Hum Reprod, 2007,22 (11) : 2903-2911.
9Crisan M,Yap S,Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs [J]. Cell Stem Cell, 2008, 3 (3) : 301-313.
10da Silva Meirelles L,Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells [J]. Stem Cells, 2008, 26 (9) : 2287-2299.
6Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex [J]. Arch Dermatol, 2002, 138(12): 1567-1576.
7Yu Y, Fuhr J, Boye E, et al. Mesenchymal stem cells and adipogenesis in hemangioma involution[J]. Stem cells,2006,24(6): 1605-1612.
8Mulliken JB, Zetter BR, Folkman J. In vitro characteristics of endothelium from hemangiomas and vascular malformations [J]. Surgery, 1982, 92(2): 348-353.
10Bentz BG, Hughes CA, Ltidemann JP, et al. Masses of the salivary gland region in children [J]. Arch Otolarygol Head Neck Surg, 2000, 126(12): 1435-1439.
